04 September 2017 – Expedia CEO Moves to Uber

Funds

University

OSI secures Legal & General backing

Imperial gives founders a choice

Government

Vertex pushes beyond $150m

Széchenyi gains $31m

St Louis hammers out fund details

Exits

Dara Khosrowshahi, the new chief executive of Uber, did not waste any time in making clear his ambitions for the ride-sharing company: in an all-hands meeting ahead of officially taking over – he starts his job on Tuesday – he declared not only that he is committed to paying the bills and taking big shots to secure the company’s future, but also that he intends to take Uber public within 18 to 36 months.

Best, a supply chain services provider backed by Alibaba, Cainiao and, reportedly, Foxconn, has increased the stakes of its initial public offering by filing an updated regulatory document that puts the figure at $1bn, up from $750m.

Berry Genomics has completed its reverse merger with Shenzen-listed Chengdu Tianxing Instrument and Meter, first announced in December 2016.

Synlogic processes Mirna merger

CSL accesses Calimmune for $91m

Western Digital gets Upthere

University

Big deal: Nightstar to light up stock market

Investments

Singapore-based Grab is slowly inching towards its $2.5bn goal for a series G round that already stood at $2bn thanks to commitments from SoftBank and Didi Chuxing.

GoGoVan reaches for 58 Suyun

Food delivery is hotly contested sector and many of the startups involved have changed hands – be that for example TastyKhana being purchased by Food Panda, which in turn was later acquired by Delivery Hero, or Just Eat subsidiary Hellofood Brazil becoming part of iFood. Now another one is joining the list: Waimai has been acquired by Ele.me for a reported $800m (which would be down significantly from the estimated $2.5bn valuation last year).

Alibaba and Yunfeng Capital, the investment vehicle of the e-commerce group’s founder Jack Ma, have put $152m into cloud computing business Qiniuyun.

Freenome, a healthtech developer has added $7m to its series A to close the round, already backed by GV, at $72m.

Armo Biosciences has added $67m to its coffers in a series C1 round that featured GV and Celgene, who both also participated in a $50m series C in February last year.

The biggest deal of the day comes from the US, where Qadium has amassed $40m in a series B round led by Institutional Venture Partners.

In China, Abcfintech has added $30m to its coffers thanks to investors such as Susquehanna International Group’s SIG Asia Investment. Abcfintech operates cloud-based AI platforms that help financial services firms visualise their data and predict the performance of public stock.

Alice, the developer of a hotel management platform, has secured $26m in series B funding from Expedia in a deal facilitated by Khosrowshahi before he stepped down to join Uber.

VideoAmp, the developer of an advertising technology platform that tracks the impact of campaigns across television, video on-demand, over-the-top and digital content, has secured $21.4m in series B capital from Mediaocean and returning backer RTL, among others.

Government

Vulog eyes $20m series B

University

CureFit exercises with $25m


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

21 March 2016 – Intel Capital, Qualcomm, Spoonrocket, Corvus Pharmaceuticals, Hutchison China MediTech, GenomeDx, LendInvest, DouyuTV, Cainiao and more

Exits

Intel Capital is reportedly looking to sell up to $1bn worth of its venture assets.

Qualcomm meanwhile looks to have scored a major exit after General Motors agreed to buy driverless vehicle technology developer Cruise Automation in a deal reportedly sized north of $1bn. Cruise, which was founded in 2013, had disclosed only $18m in debt and equity financing.

Just days after announcing it was shutting down, VC-backed SpoonRocket has been acquired by iFood, a delivery service in Latin America that has raised more than $60m from Brazil-based Movile Internet and Warehouse Investimentos, among others.

Corvus Pharmaceuticals, an oncology therapy developer backed by Roche and Novo, filed for a $115m IPO in January but has subsequently set a range between $70m and $80m. It had raised $108m in venture capital over the past two years.

Hutchison China MediTech (Chi-Med), a China-based healthcare group backed by conglomerate Mitsui, raised $101.3m when it floated on Nasdaq yesterday.

Investments

GenomeDx released a prostate cancer testing product last week and has followed it with $25.4m in series C funding, according to an SEC filing. The funding represents the first to be publicly disclosed – in terms of size anyway – for the company, which is backed by investors including Merck’s Global Health Innovation fund.

Having received £22m from Beijing Kunlun in June last year, LendInvest raised £17m from VC firm Atomico, bringing its total debt and equity financing to more than £200m.

DouyuTV, a streaming service focused on the livestreaming of video games, has raised $100m in a series B round led by Tencent, which reportedly provided more than $60m.

Alibaba’s financial services affiliate Ant Financial is said to be raising money at a $60bn valuation but its logistics spinout Cainiao isn’t doing too badly either, having raised a reported $1.54bn in a round that values it at $7.7bn.

Diversified conglomerate HNA Group has agreed to invest RMB1.2bn ($185m) in online sports streaming platform Le Sports as part of a series B round that could reach $1.08bn, according to a regulatory filing.

Ring, a US-based smart doorbell developer backed by insurance provider American Family Insurance and home builder JF Shea, has raised $61.2m in a series C round featuring Kleiner Perkins Caufield & Byers.

University College London cancer treatment spinout Autolus licences additional technology from the university as it raises $57m in its series B round.

Biotechnology startup Aprea, a spinout of Karolinska Institute that is backed by a range of public investors, has raised the biggest round for a Sweden-based life sciences company in a decade.

People

QB3, University of California’s research institute and life science accelerator, loses its associate director as Douglas Crawford steps down.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0